Outcomes following KRASG12C inhibitor treatment in patients with KRASG12C-mutated solid tumors: A systematic review and meta-analysis

• المؤلفون الرئيسيون: Qi-An Chen (مؤلف), Wei-Hao Lin (مؤلف), Xiao-Xiang Zhou (مؤلف), Zheng Cao (مؤلف), Xiao-Li Feng (مؤلف), Yi-Bo Gao (مؤلف), Jie He (مؤلف)
• التنسيق: كتاب
• منشور في: Elsevier, 2024-02-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Objective: To assess the efficacy and safety of FDA-approved KRASG12C inhibitors in patients with KRASG12C-mutated solid tumors. Methods: We searched PubMed, EMBASE, Cochrane Library, and major international conferences for clinical trials published in English up to March 6, 2023. Clinical trials in...